Skip to main content
Veterinary Medicines

ADEQUAN IM 500 MG/5 ML SOLUTION FOR INJECTION

Authorised
  • GLYCOSAMINOGLYCAN POLYSULFATE

Product identification

Medicine name:
ADEQUAN IM 500 MG/5 ML SOLUTION FOR INJECTION
Adequan IM 500 mg/5 ml Oplossing voor injectie
Adequan IM 500 mg/5 ml Solution injectable
Adequan IM 500 mg/5 ml Injektionslösung
Active substance:
  • GLYCOSAMINOGLYCAN POLYSULFATE
Target species:
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • GLYCOSAMINOGLYCAN POLYSULFATE
    500.00
    milligram(s)
    /
    1.00
    Bottle
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AX12
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Novartis Consumer Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vericore Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V209526
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0416/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/07/2023
French (PDF)
Published on: 7/07/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/07/2023
French (PDF)
Published on: 7/07/2023
German (PDF)
Published on: 7/07/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 7/07/2023
French (PDF)
Published on: 7/07/2023
German (PDF)
Published on: 7/07/2023
How useful was this page?:
Average: 1 (1 vote)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."